HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma




HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has initiated the Phase III part of the Phase II/III trial to evaluate the efficacy of the combination of surufatinib, camrelizumab, nab-paclitaxel and gemcitabine as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (“PDAC”) in China. The first patient received the first dose on December 30, 2025.

PDAC is a highly aggressive form of cancer, representing over 90% of pancreatic cancer cases. Globally, an estimated 511,000 people were diagnosed with pancreatic cancer, leading to approximately 467,000 deaths in 2022, with an average five-year survival rate of less than 10%. In China, an estimated 119,000 people were diagnosed with pancreatic cancer, causing approximately 106,000 deaths in 2022.1 Treatments such as chemotherapy, surgery and radiation are commonly employed, but have not shown significant improvement in patient outcomes. Under 20% of metastatic pancreatic cancer patients survive for more than a year. 2

The trial is a multicenter, randomized, open-label, active-controlled Phase II/III study to evaluate the efficacy and safety of surufatinib combined with camrelizumab, nab-paclitaxel and gemcitabine (“S+C+AG”) versus nab-paclitaxel plus gemcitabine (“AG”) in adults with metastatic pancreatic cancer who have not previously received systemic anti-tumor therapy. A total of 62 patients were enrolled in the Phase II part, with plans to enroll approximately 400 additional patients in the Phase III part. The primary endpoint for the Phase III part is overall survival (OS). Secondary endpoints include progression-free survival (“PFS”), objective response rate (“ORR”), duration of response (DoR), disease control rate (“DCR”), quality of life and safety. Professor Shukui Qin of China Pharmaceutical University Nanjing Tianyinshan Hospital and Professor Jihui Hao of Tianjin Medical University Cancer Institute and Hospital are the leading principal investigators of this study. Additional details may be found at clinicaltrials.gov, using identifier NCT06361888.

Results from the Phase II part were recently presented at the 2025 European Society for Medical Oncology (ESMO) Asia Congress.3 As of the data cut-off of July 24, 2025, the median PFS follow-up duration was 8.15 months. The S+C+AG regimen demonstrated a median PFS of 7.20 months compared to 5.52 months for the AG arm (stratified hazard ratio [HR] 0.499, log-rank p=0.0407), representing a 50.1% reduction in the risk of progression or death. Consistent benefits were observed across other key efficacy endpoints, including ORR (67.7% vs 41.9%, p=0.0430) and DCR (93.5% vs 71.0%, p=0.0149). Although overall survival data were immature at the time of analysis, a favorable trend was observed (not reached vs 8.48 months, unstratified HR 0.555), with 9 events in the S+C+AG arm (N=31) and 15 events in the AG arm (N=31). The safety profile was manageable. Treatment-emergent adverse events (TEAEs) of grade 3 or above occurred in 80.6% of patients in the S+C+AG arm compared to 61.3% in the AG arm.

About Surufatinib

Surufatinib is a novel, oral angio-immuno kinase inhibitor that selectively inhibits the tyrosine kinase activity associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptor (FGFR), which both inhibit angiogenesis, and colony stimulating factor-1 receptor (CSF-1R), which regulates tumor-associated macrophages, promoting the body’s immune response against tumor cells. Surufatinib is marketed in China by HUTCHMED under the brand name SULANDA®. HUTCHMED currently retains all rights to surufatinib worldwide.

About Camrelizumab

Camrelizumab (SHR-1210) is a humanized monoclonal antibody targeting the programmed death-1 (PD-1) receptor. Camrelizumab has been approved in China for multiple indications in areas such as lung cancer, liver cancer, esophageal cancer, nasopharyngeal cancer and cervical cancer. Camrelizumab is marketed in China by Hengrui Pharma under the brand name AiRuiKa®.

About HUTCHMED

HUTCHMED (Nasdaq/AIM:​HCM; HKEX:​13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Since inception it has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three medicines marketed in China, the first of which is also approved around the world including in the US, Europe and Japan. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the US Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect HUTCHMED’s current expectations regarding future events, including its expectations regarding the therapeutic potential of surufatinib for the treatment of PDAC and the further development of surufatinib in this and other indications. Forward-looking statements involve risks and uncertainties. Such risks and uncertainties include, among other things, assumptions regarding the timing and outcome of clinical studies and the sufficiency of clinical data to support a new drug application submission of surufatinib for the treatment of PDAC or other indications in China or other jurisdictions, its potential to gain approvals from regulatory authorities on an expedited basis or at all, the efficacy and safety profile of surufatinib, HUTCHMED’s ability to fund, implement and complete its further clinical development and commercialization plans for surufatinib and the timing of these events. In addition, as certain studies rely on the use of other drug products such as camrelizumab, nab-paclitaxel and gemcitabine as combination therapeutics with surufatinib, such risks and uncertainties include assumptions regarding the safety, efficacy, supply and continued regulatory approval of these therapeutics. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. For further discussion of these and other risks, see HUTCHMED’s filings with the US Securities and Exchange Commission, The Stock Exchange of Hong Kong Limited and on AIM. HUTCHMED undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

Medical Information

This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.

CONTACTS

Investor Enquiries +852 2121 8200 / ir@hutch-med.com
   
Media Enquiries  
FTI Consulting – +44 20 3727 1030 / HUTCHMED@fticonsulting.com
Ben Atwell / Tim Stamper +44 7771 913 902 (Mobile) / +44 7421 898 348 (Mobile)
Brunswick – Zhou Yi +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com
   
Panmure Liberum Nominated Advisor and Joint Broker
Atholl Tweedie / Emma Earl / Rupert Dearden +44 20 7886 2500
   
Cavendish Joint Broker
Geoff Nash / Nigel Birks +44 20 7220 0500
   
Deutsche Numis Joint Broker
Freddie Barnfield / Jeffrey Wong / Duncan Monteith +44 20 7260 1000

______________________________

REFERENCES
The Global Cancer Observatory, China fact sheet. https://gco.iarc.who.int/media/globocan/factsheets/populations/160-china-fact-sheet.pdf. Accessed December 3, 2025
2 Sarantis P et al. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol. 2020;12(2):173-181. DOI:10.4251/wjgo.v12.i2.173
3 Qin S et al. 375P – Surufatinib (S) in combination with camrelizumab (C), nab-paclitaxel and gemcitabine (AG) as the first-line treatment in metastatic pancreatic cancer: Results from phase II part of a randomized, open-label, active-controlled, phase II/III study. Annals of Oncology (2025) 36 (suppl_4): S1859-S1939. 10.1016/annonc/annonc1989


CystoSmart™, an AI Software Tool for Bladder Cancer Detection, Developed with Cutting-Edge Technology Receives Clearance from Health Sciences Authority Singapore

CystoSmart™, an AI Software Tool for Bladder Cancer Detection, Developed with Cutting-Edge Technology Receives Clearance from Health Sciences Authority Singapore




CystoSmart™, an AI Software Tool for Bladder Cancer Detection, Developed with Cutting-Edge Technology Receives Clearance from Health Sciences Authority Singapore

SINGAPORE and LONDON and NEW YORK, Jan. 04, 2026 (GLOBE NEWSWIRE) — Intelligent Scopes Corp (“ISC”), specializing in state-of-the-art image enhancement and precision AI software solutions for urology and gastroenterology, is pleased to announce that CystoSmart™ has received regulatory clearance from Health Sciences Authority (HSA), the National Regulatory Agency for medical products and devices in Singapore.

CystoSmart™, an AI software tool for bladder tumor detection in patients undergoing screening and surveillance endoscopic examination of the bladder is brand agnostic and compatible with flexible and rigid scopes, including single-use scopes. The device is intended to be used with white light cystoscopy to aid clinicians in improving detection accuracy of bladder tumors in real-time and post processing conditions.

The HSA clearance for CystoSmart™, which comes eleven months after it was approved by ANVISA, the Brazilian medical devices regulator, marks a significant milestone. Not only does it clear CystoSmart™ for use in Singapore, but, through the ‘Access Consortium’ collaboration, it paves the way for accelerated regulatory clearances in Australia, Canada, Switzerland and United Kingdom, countries that are part of the Access Consortium group.

Bladder cancer is the tenth most common cancer worldwide, and the sixth most common malignancy in men. With increasing incidence globally, bladder cancer has a high rate of progression and recurrence (up to 80%) requiring repeated follow up examinations. White light cystoscopy is the standard and most widely used method for bladder tumor detection and surveillance, however, as per published studies, between 10% and 20% of bladder tumors are regularly missed by standard white light cystoscopy.

Dr Rajesh Nair, Chief Surgical Officer of ISC, commented, “Early identification of cancer translates to improved clinical outcomes, impacting positively on the patient journey and overall health economy.  Accurate exclusion reduces inappropriate investigations which carry a physical and psychological burden for patients. Early detection or exclusion of bladder cancer allows for more effective resource utilisation.” He added, “CystoSmart™ can be used as an aid for urologists to improve detection accuracy: to reduce missed tumors and reduce unnecessary invasive biopsies and interventions.

As per clinical and technical evaluations conducted, CystoSmart has a sensitivity (true positive rate) of over 95% and a specificity (true negative rate) of over 98% in bladder tumor detection thereby aiding clinicians to improve accuracy.

About Intelligent Scopes Corp

Intelligent Scopes Corp, subsidiary of Claritas HealthTech, leads global deployment of endoscopic solutions. The company provides state-of-the-art image processing and enhancement software medical devices and AI diagnostic tools for the fields of urology and gastroenterology. The company focuses on image processing, image enhancement, AI diagnostic tools, and robotic guidance systems for endoscopy procedures to improve detection rates, reduce unnecessary biopsies and enhance patient outcomes.

For more information, please visit: www.intelligentscopes.com.

For Enquiries, please contact:
Devika Dutt
COO
Intelligent Scopes Corp
d.dutt@intelligentscopes.com

Best Male Enhancement Pills 2026: Launched By Performer 8′ Over The Counter ED Pills For Erectile Dysfunction, Growth & Last Longer for Men

Best Male Enhancement Pills 2026: Launched By Performer 8′ Over The Counter ED Pills For Erectile Dysfunction, Growth & Last Longer for Men




Best Male Enhancement Pills 2026: Launched By Performer 8′ Over The Counter ED Pills For Erectile Dysfunction, Growth & Last Longer for Men

best male enhancement pills sold in stores’ Pills for Erectile dysfunction for men, Effective Formula for last longer and testosterones booster Quality Criteria Examined in New Industry Analysis New

York City,, Jan. 04, 2026 (GLOBE NEWSWIRE) —

In 2026 Having erectile dysfunction or poor performance in the bedroom can ruin a man’s self-esteem, crush their confidence, and leave their partner feeling empty and sexually unfulfilled.

Luckily, there are Best male enhancement pills on the market that can help you get your groove back. In fact, thousands of men all over the world rely on male enhancement supplements for bigger erections, increased libido, and improved sexual performance.

But with so many male enhancement pills to choose from, how do you know which product is best for your specific needs?

Why “Best Male Enhancement Pills for Men” Matters for Your Sexual Health Goals

For many men, achieving peak sexual performance involves more than desire alone. Age, stress, lifestyle habits, and natural hormonal changes can gradually affect libido, stamina, and confidence. Common challenges include:

  • Reduced sexual drive due to fatigue or mental stress
  • Weaker or inconsistent erections linked to poor blood flow
  • Low stamina that limits performance and satisfaction
  • Confidence issues that impact intimacy and relationships

The best male enhancement pills for men are designed to target these concerns at the root. Instead of offering temporary stimulation, high-quality supplements support healthy circulation, natural testosterone activity, and sustained energy levels. This helps men restore performance, confidence, and consistency in a safe and balanced way.

Well-formulated male enhancement supplements focus on men’s sexual health needs by combining research-backed ingredients that improve blood flow, enhance sensitivity, and promote endurance. When paired with a healthy lifestyle, they can deliver noticeable results without extreme methods or harmful substances.

⭐ Top Pick Performer: Performer 8

Performer 8 stands out as a top male enhancement supplement for men seeking real, long-term results. Its advanced formula is designed to boost blood flow, support testosterone levels, and enhance libido naturally. With carefully selected ingredients and transparent dosing, Performer 8 helps promote firmer erections, improved stamina, and greater confidence—making it a trusted choice for men serious about their sexual health goals.

How Quality Male Enhancement Pills Are Selected

Not all male enhancement products are effective. The best options are chosen based on:

  • Scientifically supported ingredients
  • Proper, effective dosages
  • Transparent labels with no hidden blends
  • Strong safety and manufacturing standards
  • Positive user reviews and proven results

Key Benefits of Male Enhancement Pills for Men

  • Stronger, longer-lasting erections
  • Increased libido and desire
  • Enhanced stamina and endurance
  • Improved confidence and mental focus

Together, these benefits support a complete approach to male sexual wellness and performance.

Choosing the best male enhancement pills for men matters because sexual health is closely linked to overall confidence, energy, and quality of life. The right supplement can support healthy blood flow, stamina, and libido, helping men perform at their natural best without extreme measures. Quality formulas focus on well-researched ingredients, proper dosing, and safety, rather than quick fixes or exaggerated promises. When sexual wellness is addressed correctly, it can improve relationships, self-esteem, and mental well-being. Making an informed choice ensures you support long-term sexual health goals while avoiding ineffective or unreliable products that may deliver little real value.

To help you decide, we’ve reviewed the top male enhancement brands and evaluated them on a variety of factors including ingredients, benefits, customer reviews, price, and value.

If you’re ready to reignite your sex life and satisfy your partner like never before, here are the best male enhancement pills on the market.

Best Male Enhancement Pills of 2026

#1 Performer 8: Best Overall

Performer 8 is our top choice for the best male enhancement pill of 2026. While women receive a “second peak” of sexual boost in their 40s, men tend to see their libidos decline. Some of Europe’s most highly regarded scientists and industry experts are changing that with male enhancement pills. The result: Performer 8.

Performer 8 stands out as the best male enhancement supplement on the market. The natural and effective formula lets you please your partner like never before. That includes boosting your sexual stamina, providing firmer erections, and raising your sperm count.

The supplement works by increasing the nitric oxide (NO) levels in the blood. This molecule allows the blood vessels to relax and widen. The more nitric oxide you have in your body, the better your blood flow and the easier it is to achieve and maintain an erection.

The ingredients in Performer 8 include muira puama, ashwagandha, ferrous bisglycinate, maca root, panax ginseng, pine bark extract, horny goat weed, grape seed extract, and glucuronolactone.

Each bottle of Performer 8 has optimized dosage and powerful natural ingredients. All you have to do is take the recommended number of pills each day. Thanks to the organic formula, you’ll have minimal chances of side effects.

Performer 8 offers an all-in-one boost to sexual performance. The pills can give you the best erection quality of your life while also improving your sexual stamina and sperm count. Best of all, this product comes with a lifetime money-back guarantee.

Click Here for the Lowest Price on Performer 8

Best Male Enhancement Pills 2026: What This Analysis Covers and Who It Is For

If you’re researching the best male enhancement pills for men in 2026, chances are you’ve already seen bold ads and big promises online—and decided to look for real information before making a purchase. That’s a smart move. The male enhancement market is crowded, competitive, and often driven more by marketing hype than by facts. Knowing how to evaluate products properly helps protect both your health and your money.

This analysis is created for men who are considering natural male enhancement supplements as part of their sexual wellness goals in 2026. It’s especially useful for men who want to understand how these products work, what ingredients matter, and how to spot quality formulas instead of relying solely on promotional claims. It’s also for men who want clear, honest insight into what supplements can realistically support—and when professional medical advice may be the better option.

In this guide, the term best is used only as a comparison tool. It refers to how products measure up against commonly researched criteria such as ingredient transparency, formulation quality, safety standards, and available research—not as a promise of results or a guarantee of performance for any individual.

What you’ll find here is a structured breakdown of the key factors that separate well-designed male enhancement supplements from low-quality alternatives. Using Performer 8 Male Enhancement as a reference point based on publicly available information, this analysis explores ingredient science, usage expectations, safety considerations, age-related factors, and realistic outcome guidelines.

Additional background resources may be referenced for educational purposes only. They are included to support independent research and do not imply endorsement or medical approval.

How Do Natural Male Enhancement Pills Work?

Many male enhancement pills work the same way. They elevate the body’s nitric oxide production, increasing blood flow to the muscle as a result. Of course, this mechanism doesn’t apply to all male enhancement supplements. Some products, like Semenax, work because the ingredients tell the testes to create more sperm.

Nitric oxide is the key that unlocks superior sexual performance and health. It can make erections stronger and firmer within minutes. It’s why erectile dysfunction products like Cialis, Levitra, and Viagra use elevated nitric oxide levels as a treatment. The compound serves multiple functions in the body. These include relaxing the muscles in the blood vessels. When the male muscles relax, that act allows the body to circulate more blood through the main vein. In other words, nitric oxide works as a vasodilator.

While you can find nitric oxide in leafy green vegetables and citrus fruits, your body may not make enough of it naturally. The best male enhancement pills send signals to your system to produce more. This process is not the same as the supplements containing nitric oxide because, in this case, your body is making more of it.

Your blood vessels aren’t the only things that benefit from nitric oxide. The biological messenger can combat inflammation and soreness, making it ideal as a post-workout supplement. Other benefits include improved memory, sleep quality, athletic performance, immune system, strength, and oxygen levels in the blood.

Older men stand to benefit the most from vasodilators. They tend to have an increased risk for erectile dysfunction and may suffer lower sex drive and testosterone levels. The right male enhancement supplement can combat aging, blood flow problems, and lifestyle factors such as high alcohol consumption and smoking.

Things to Look for When Buying the Best Male Enhancement Supplements

Quality Ingredients:

What you put in your body matters. Make sure your male enhancement pills have high-quality, potent ingredients that deliver optimized benefits with no side effects. Some performance-enhancing natural ingredients to look for include Ginkgo biloba, Tribulus terrestris, Panax ginseng, L-methionine, and L-arginine HCL.

Every ingredient has a distinctive purpose. When researching male enhancement supplements, double-check that the formula helps you achieve your goals. For example, Ginkgo biloba increases blood flow to the male, while Tribulus terrestris can improve urinary tract health, reduce inflammation, and boost testosterone production for males over 40.

Clean Labeling:

Clean labeling is a must when purchasing male enhancement pills. You should know every ingredient that goes into your body. The last thing you want is to have an allergic reaction because a manufacturer claims to have a proprietary formula. While there’s a time and place for proprietary formula, male enhancement supplements are not one of them. The discreet approach lets unscrupulous companies put fillers and synthetic compounds into the sex pills so that they can turn a quick profit. The best male enhancement pills have clean labels that list the ingredients in the supplement.

Money-Back Guarantee:

Money-back guarantees provide peace of mind to consumers. If a male enhancement pill doesn’t deliver results, you can return it for a complete refund. All of the companies on our list let users try the supplement for two to three months risk-free. Money-back guarantees give you a chance to see how effective a product is. Do you notice changes to your testosterone levels or sexual desire? Do you have higher energy levels and lower rates of erectile dysfunction? The trial period allows you to answer those questions without financial risk.

Positive Feedback:

Customer reviews provide a behind-the-scenes look at the consumer experience after people purchase male enhancement supplements. They let you know if products work for real people like they do in the commercials. Thorough and informative customer reviews can provide the push you need to select one pill over another.

We prioritized male enhancement pills that had glowing reviews. Products like VigRX Plus and Max Performer receive consistent critical praise and have scientific studies backing their efficacy. You can have confidence knowing that these pills will improve your testosterone levels, sexual desire, and male size instead of only claiming that they can. You can also read detailed testo max here.

Made in the USA:

It’s never been more important to invest in American-made products. Instead of sending your hard-earned dollars abroad, you can bolster your local economy and support blue-collar jobs. Buying male enhancement pills that say “Made in the USA” ensures that your dollars will support American workers and their families.

You don’t have to worry about quality when you buy pills produced in the USA. The Food and Drug Administration oversees manufacturing facilities, checking that they have up-to-date equipment and clean work environments. This oversight guarantees the highest-caliber working conditions possible.

Benefits of Taking Male Enhancement Pills

Most men take male enhancement pills to improve their sex life. The supplements work for users of all ages as they overcome everything from erectile dysfunction to low libido. Products like Performer 8 deliver a wide range of benefits that amplify male sexual performance.

Some pills have narrowly tailored benefits, like Semenax. This supplement magnifies orgasm intensity, making each climax more rewarding. It increases penile sensitivity during intercourse, making the experience more satisfying for you and your partner.

Other men want longer-lasting erections. VigRX Plus prolongs erections by relaxing the blood vessels and generating more blood flow to their members. Men that take VigRX Plus report stronger and more enduring erections.

Finally,male enhancement pills can make men feel like “men” again. Some products increase testosterone levels, instilling guys with the strength and vigor they had in their youth. The supplements can seem to turn back time and, in the process, make sex more exciting and rewarding.

Male Enhancement 

Some people use male enhancement and male enlargement synonymously, but they are different things. Male enhancement supplement products focus on boosting male sexual health, while male enlargement tools involve lengthening the genitalia. Understanding the difference can help you make an informed decision when shopping for supplements and male enlargement devices.

We’ve already touched on male enhancement products. Most of these oral supplements increase blood flow to the male, resulting in firmer and thicker erections. Some pills provide a natural boost of testosterone production and energy, too.

Male enhancement products cater to individuals who want to upgrade their sex lives. Perhaps you struggle with erectile dysfunction or a low sperm count. These supplements resolve underlying issues, restoring your sex drive to that of a 20-year-old.

male enlargement comes in several forms. The three most common methods are male pumps, traction devices, and male surgery. While each option makes the genitalia longer, each does so in distinct ways.

A male pump creates a high-pressure environment that increases blood flow to your male temporarily. Men that use such a device can maintain a firm erection for half an hour or more. It makes penetrative sex with a partner more manageable and efficient.

A male pump goes over your genitals, forming a tight seal with the skin around the base. If you haven’t shaved your pubic hair, you should do so before using the device. It’s no fun having stray hairs snag in the tube.

Once the device is in place, turn on the motor or use the hand pump to remove the air. As the chamber pressurizes, it draws blood toward the tip of the male. The result is a thicker erection without the need for prescription medication or surgical intervention.

Traction devices, also known as male extenders, are medical products to correct Peyronie’s disease. This condition involves an unnatural curvature of the male due to plaque or fibrous tissue. Individuals have to wear the device for several hours per day to straighten and lengthen their male.

A study from Live Science had 15 men use traction devices for six months. The men increased the amount of tension on the shaft from 1.3 pounds to 2.6 pounds midway through the experiment. The result was a 0.9-inch improvement in flaccid male length.

Outside of surgery, traction devices are the only way to enhance male size permanently. The products use carefully calibrated tension to lengthen the genitalia through micro-tears. However, men must wear them for roughly eight hours a day, making them painful and cumbersome at times.

male surgery serves as the most extreme form of male enlargement. It involves a surgeon placing a silicon sheath underneath the skin to lengthen the male. Insurance does not cover this procedure, so you will have to pay the approximately $15,000 medical bills out-of-pocket.

male surgery is simple and straightforward. A surgeon places you under general anesthesia and inserts the sheath. You’ll have to go to a follow-up appointment two or three days after the operation.

According to Dr. James J. Elist, a Beverly Hills urologist specializing in penile treatments, male surgery can improve male length and girth. The average man stands to add 1.5 inches in length and one inch in girth while flaccid. People that have male surgery have average erections of 7.7 inches after the procedure.

Who Should Take Male Enhancement Pills?

Erectile dysfunction is more common than you might think. According to a Danish study from 2018, roughly one-third of men have some form of erectile dysfunction. The condition appears more frequently and becomes more severe the older you get.

Why do older men have higher rates of erectile dysfunction? There isn’t one answer. Instead, erectile dysfunction is a byproduct of aging, with older men having lower energy levels, testosterone levels, and sex drive.

Male enhancement pills provide a safe and reliable way to combat aging. They can revitalize your sexual desire, giving you the stamina and erection quality you need to please your partner. The supplements let you fight back against Father Time and Mother Nature.

You don’t have to be in middle age or retirement to need male enhancement supplements. Some men have poor circulation, making it challenging for them to achieve erections despite being in excellent health otherwise. Other individuals take supplements like Semenax to raise their odds of conception since it can improve sperm count and motility.

Even the best male enhancement pills can’t work miracles, though. If you want to overcome erectile dysfunction or low testosterone levels, you should use them with diet and exercise. The holistic approach ensures that your body is the fittest and healthiest version of itself.

Do Male Enhancement Pills Have Any Side Effects?

Most organic male enhancement pills have no side effects. The wholesome formulas deliver the increased sex drive and blood flow you want with minimal chance for an allergic reaction.

Note that you do have a slim chance of experiencing side effects, though. Some people have dry mouths, nausea, and low energy levels. These side effects should only last for a few hours. If symptoms persist for several days, you should contact your primary care physician.

People have used compounds like Asian red ginseng and Tribulus terrestris for centuries. These practical and reliable compounds give you the best chance of taking your sex drive up a notch.

Always make sure to read the label before purchasing supplements. Leading manufacturers include a complete list of ingredients on the label so that you can do your research ahead of time. If you’re unsure about the formula, talk with your local doctor.

Does Performer 8 Actually Work?

Research cited within the male enhancement supplement category shows that certain ingredient combinations have been associated with improvements in sexual performance markers when compared to placebo over 12-week periods. Studies on similar formulations have reported statistically meaningful results. However, these findings do not represent direct clinical testing of the finished Performer 8 product. Individual results vary—some men notice clear benefits, while others may experience minimal changes. The satisfaction guarantee allows users to try Performer 8 and evaluate its effectiveness with reduced financial risk.

How Long Does Performer 8 Take to Work?

Performer 8 is formulated as a daily supplement intended to support the body gradually. According to manufacturer guidance and category research, noticeable results typically develop with consistent use over several weeks, with many studies assessing outcomes around 12 weeks. This is not an instant or on-demand product.

Is Performer 8 Safe?

Performer 8 contains natural, plant-based ingredients. However, natural supplements are not automatically suitable for everyone. Men with medical conditions, those taking prescription medications, or individuals with specific health risks should consult a healthcare professional before use.

Is Performer 8 FDA Approved?

Performer 8 is a dietary supplement, not a prescription medication. Dietary supplements are regulated differently and are not approved by the FDA for effectiveness prior to sale. The standard disclaimer applies: this product is not intended to diagnose, treat, cure, or prevent any disease.

How Does Performer 8 Compare to Prescription Options?

Prescription treatments for erectile dysfunction are FDA-approved and supported by extensive clinical data with defined timelines. Performer 8 is a natural supplement that works through a different mechanism and evidence profile. It requires consistent daily use over time, and results can vary significantly between individuals.

Can I Take Performer 8 With My Medications?

This should be discussed with your healthcare provider. Some botanical ingredients may interact with medications, especially those related to heart health, blood pressure, blood thinning, diabetes, or circulation.

How Does Performer 8 Compare to Other Products From the Same Manufacturer?

The manufacturer offers several male wellness supplements, each designed for different performance and health goals. Some men explore more than one option to find the best fit. The shared guarantee policy helps reduce financial risk during evaluation.

Can Performer 8 Help With Fertility?

Performer 8 is formulated to support sexual performance, not fertility. While some ingredients have been researched in fertility contexts, the product is not positioned or marketed as a fertility supplement. Men with fertility concerns should seek professional medical advice.

Why Do Some Reviews Say Performer 8 Doesn’t Work?

Responses to supplements vary widely. Factors such as age, baseline health, consistency of use, expectations, and underlying causes of sexual concerns all influence results. Mixed reviews are common in this category and reflect normal individual differences.

What If Performer 8 Does Not Work for Me?

According to company policy, customers can request a refund under the satisfaction guarantee if the product does not meet expectations. If supplements are insufficient, consulting a medical professional to explore other options may be appropriate.


Final Considerations: Making Your Decision

Choosing a male enhancement solution is a personal decision based on health status, goals, and preferences. This information is intended to support informed decision-making, not replace medical advice.

Key Takeaways

  • Quality male enhancement supplements are evaluated based on ingredient research, formulation transparency, manufacturing standards, safety information, and refund policies.
  • Performer 8 aligns with many commonly cited quality benchmarks based on publicly available disclosures.
  • Supplements work best when combined with healthy lifestyle habits.
  • Medical consultation is important for men with health conditions or those taking medications.

Next Steps

If Performer 8 fits your needs, review the latest label details, policies, and availability on the official website.
Always consult a healthcare provider before starting any new supplement.
If natural options do not deliver adequate results, professional medical evaluation may help identify alternative solutions.

Can You Buy male Enhancement Pills Over-the-Counter?

Yes, you can find over-the-counter natural male enhancement supplements. Most of these pills treat erectile dysfunction, like sildenafil. They stimulate blood flow to the male, making it easier for men to achieve an erection.

The problem is that over-the-counter medications you can find at your local pharmacy don’t have the same power as the stuff you find online. These male enhancers have lower levels of key ingredients, making them less effective overall. Shop online if you want the best possible results for your erection quality and male size.

Official Website: :https://performer8.com/

Contact Details: Performer 8

Email: support@performer8.com

Phone: +1(929) 242-4275

Advertise with us: Info@allprsolution.com

Best Over The counter Sleep Aid 2026: Launched By NooCube Strongest natural sleep aid, Pills For Sleep And Anxiety Without Side effects

Best Over The counter Sleep Aid 2026: Launched By NooCube Strongest natural sleep aid, Pills For Sleep And Anxiety Without Side effects




Best Over The counter Sleep Aid 2026: Launched By NooCube Strongest natural sleep aid, Pills For Sleep And Anxiety Without Side effects

Strongest sleep aid over the counter sleep Pills NooCube best for sleep and anxiety read side effects, benefits, ingredients of NooCube supplement

New York City, Jan. 04, 2026 (GLOBE NEWSWIRE) —

In 2026 Getting good sleep is more like a habit that some people cannot make due to hectic lifestyles. Over the counter, sleeping pills aren’t synthetic drugs but natural supplements which we are going to discuss below. 

They do not have side effects like most pharmaceuticals prescription-based sleeping pills available in the pharmacy. Speaking of OTC sleeping pills, NooCube Sleep is the best otc sleeping aid supplement to attain unmatched effectiveness and sleep quality. Click here to visit noocube sleep official website.

Sleep is like charging the battery of humans which gives you enough rest to carry on with the next day. Getting good sleep is closely linked to a healthy life and healthy brain functioning. Those people who take a good night’s sleep regularly tend to be sharp learners, memorizers, and good rapid decision makers because their cognitive skills are just to the point.

Insufficient sleep is associated with many serious and life-threatening diseases such as cardiovascular incidents, obesity, diabetes, and loss of focus or concentration. Sleep is a natural phenomenon that occurs daily but still around 20% of people are unable to get it every night, thus they develop occasional symptoms of insomnia.

Studies by the National Sleep Foundation show that sleep problems are more commonly reported now than ever before, so it should be no surprise that demand for sleeping medications is at an all time high. There are some people dealing with sleep issues that still find themselves asking are sleeping pills safe though.

A lot of this confusion comes from a lack of understanding on the difference between prescription drugs and over the counter sleep aids. While both can be used to treat severe insomnia patients, that latter is undoubtedly much safer and a far better choice for people who just have a little trouble falling asleep.

That is why we have created our guide to the best OTC sleep aids and prescription sleep medications. This will give you all of the information that you need to choose the perfect sleep aid to help combat any sleep disorder, optimise your sleep wake cycle, or simply just improve sleep habits, no matter your own situation.

Best Sleeping Pills Over the Counter

The thing about OTC medicines is they can be purchased without a prescription and most of them are sold in every pharmacy nearby. OTC medications can also be found in many supermarkets and drug stores since they don’t require direct FDA approval, however, the active ingredient must be FDA-approved. Click here to read more about sleeping pills online

FDA is responsible for the streaming of the best sleeping pills in the market and also their distribution takes place in the right hand.

There are countless brands of the counter sleeping pills most of which are antihistamines that are used against allergies. Since allergy medication induces drowsiness, this made them used as OTC sleeping aid.

Best Over the Counter Sleeping Pills

OTC sleeping aids are preferred over sleeping drugs because OTC versions improve the overall sleep experiences of the users.

Melatonin is put in most natural sleep aids as studies on behavioral sleep medicine show it is among the very best ways to help you sleep. However, some people avoid it as it can cause side effects like nightmares or frequent urination in certain people, making it even harder to sleep.

NooCube Sleep Upgrade is one of the most popular natural sleep aids for people in this group, as it specifically omits melatonin from its formula.

It instead contains:

  • Magnesium
  • Calcium
  • Vitamin d
  • Lemon balm leaf powder
  • Lavender extract

Sleeping aids for which you don’t need a prescription and are available over the counter are:

      1.   Melatonin

Melatonin is a natural hormone produced by the body to make it sleep. The hormone makes signaling to the brain that it’s time to sleep, however, in sleep-deficient people the levels of melatonin are greatly reduced. Melatonin production and release depends on the time of the day, typically it increases naturally in the evening and falls in the morning.

Melatonin supplements are popular sleeping aid in 2026 and are mainly used by individuals having an impaired melatonin cycle. In many studies, a connection was established between melatonin production and daytime sleep quality. Men and women such as shift workers whose schedule requires them to sleep during the daytime.

Melatonin does not just improve sleep quality but it can also mend fewer sleep disorders. The compound reduces the time people need to fall asleep or in other words, sleep latency, and it increases the total amount of time you sleep.

      2.   Valerian Root

Searching for the best OTC sleeping pills, you may always find valerian root which is a common treatment for anxiety, depression, and menopause symptoms. In US, Europe, and Asia, Valerian Root supplements are the most common sleeping aid which shares different results based on a person’s mental health.

Valerian supplements tend to work better in menopausal and postmenopausal women whose sleep quality was greatly affected before. After taking valerian, they claimed to have better sleep quality with diminished symptoms of a sleep disorder.

      3.   Glycine

Glycine is a typical amino acid that plays a main role in the central nervous system by improving sleep patterns. The exact mechanism of action of glycine is unknown, but it is thought to play a main part in lowering the body temperature during sleep.

In a study conducted in 2006, participants who consumed around 3 grams of Glycine slept more immediately than those who took a placebo. Individuals in the glycine group also reported less fatigue the next morning with feelings of liveliness and mental clarity. You can find Glycine supplements as the counter sleeping aid in nearby stores.

      4.   Cannabidiol

CBD is a hemp-derived compound that features oils, capsules, tinctures, and balms. Since CBD contains no or less amount of THC so the psychoactive effects are absent but the CBD gets you the highest quality sleep.

In many studies, it was confirmed that CBD alleviates anxiety and acts as a natural sleeping aid. Many studies confirmed CBD could reduce the symptoms of insomnia when used alone.

      5.   Lavender

Lavender plant is found in numerous regions of the world, the plant bears purple flowers that are dried and then used for medicinal and household purposes. Lavender has a distinct and soothing fragrance that enhances sleepy feelings. Several studies confirm that just smelling lavender oil before sleep is enough to improve sleep quality, esp in individuals with insomnia complaints.

A study with older adults with dementia suggested going under aromatherapy with lavender oil. The therapy is effective at improving sleep disturbances symptoms. The total sleep time of users also increased with only a few people waking up early and being unable to get back to sleep.

      6.   Magnesium

Hundreds of minerals are there but only magnesium is involved with hundreds of processes in the body including brain and heart functions. Magnesium is a trace mineral that could make it easier for a person to sleep by inducing quietness.

Studies have suggested magnesium has relaxing effects which can be potentially beneficial for regulating melatonin production. Magnesium relaxes the muscles and induces sleep!

There are many forms of magnesium available but most people combine magnesium with other sleeping aids including glycine and melatonin. One study demonstrated the effects of the magnesium, vitamin B, and melatonin combination which were greatly effective for treating asymptomatic insomnia.

Magnesium is the key to increasing GABA levels, Gamma Aminobutyric Acid is a messenger in the brain with calming effects as its features.

      7.   Passionflower

Also known as PassifloraIncarnata is an herbal remedy for insomnia. This species of flower is associated with sleep improvements that first came from North America. Passionflower sleeping aid benefits have been tested in animal studies although more data is to be compiled for human subjects.

A study compared the effect of passionflower tea and a placebo made from parsley leaves, each participant drank each tea about an hour before bedtime for 1 week. Participants who drank passionflower tea noticed lucid dreaming and immediate sleep more than the placebo group.

Best Sleeping Pills by NooCube

Struggling to sleep is like fighting a never-ending battle and switching sides to another in bed continuously. Insomnia is a distressing condition that can take out all the liveliness in your life and it makes you cranky, tired, and less creative with impaired mental and physical performances.

There is so much commonality among insomnia patients as 35% of the adults deal with different severe conditions. There are three types of insomnia and chronic insomnia is the most severe one.

To resolve this issue, the best thing according to the experts is over-the-counter sleeping pills available on the market.

Currently, millions of people are searching for the right sleeping aids but most prefer the OTC ones.

This section is to tell whether you can buy the best sleeping pills in the stores online.

  • Best OTC Sleeping Pills GNC

At GNC, you can find CBS gummies that may not be the right solution since it comes along. Although melatonin lozenges didn’t work in most people who purchased it from GNC and tried it for almost a year. Note, to make melatonin work, you may take it in capsule form or higher dosages. GNC may be a good place for dietary supplements but it doesn’t have the best sleeping aid of 2026 – which means NooCube Sleep.

  • Sleeping Pill Walmart

Walmart has several sleeping aids and most of them contain Diphenhydramine HCL which is not OTC sleeping aid. Even if you can buy these products over the counter, you may be informed about the negative consequences of Diphenhydramine which affects the cardiovascular as well as the entire nervous system.

Nearly 90% of sleeping pills at Walmart have pharmaceutical chemicals inside and not the ones we speculated about and mentioned above. Such chemicals hold the ability to habit-forming and they can be purchased from any pharmacy nearby.

  • Over the Counter Sleeping Pills Walgreens

Just what we were talking about, even Walgreens are short of over-the-counter sleeping pills. The products related to sleep you can find there have doxylamine succinate or diphenhydramine which is again, a habit-forming chemical and is not recommended for someone battling against insomnia. Most sleeping aid products on Walgreens have FDA-approved drugs but unless the doctor hasn’t prescribed you the medication, it would be risky to rely on such compounds for sleep induction.

  • Best Sleeping Pills Over the Counter

Only a small number of melatonin supplements are found on Amazon and there is nothing you can find in there besides chemical-based sleeping pills. Organic nighttime sleeping aid are available on Amazon but there is a need for looking out for their manufacturer as most products sold on Amazon have no manufacturing details. These are the products from third-party sellers who may or may not be trustworthy.

Sleeping Pills Near Me


If you are looking for sleeping pills nearby, you should stop your quest right now because the best OTC sleeping aid can be found online.

Men and women from different countries of the world search for the same thing although the search engine presents them according to their region.

Let us see which country sleeping pills are becoming popular and what should they do to get their hands on the best one.

  • Best Sleeping Pills USA

There are countless sleeping pills in the USA most of which are found in cough syrup and antihistamine medications. Despite the FDA warnings, US people abuse sleeping pills as they get a different type of arousal from consuming them. This is why the trend of OTC sleeping aids is rising fast in the US for putting drug abuse to an end.

  • Best Over the Counter Sleeping Pills UK

You may see UK people chugging Benadryl syrup because it contains multiple antihistamines which induce sleep immediately. You can also find the best over-the-counter sleeping pills in the UK but that wouldn’t be from Barrett and Hodgson or boots pharmacy. Again, you have to go online and find the website of our best-sold and top-ranked sleeping pills over the counter.

  • Sleeping Pills Canada

By the reports, nearly 1/3rd people of in Canada take sleeping pills on regular basis. These are either sedative or hypnotics or tranquilizers which affects the brain or spinal cord. Doctors and healthcare providers only prescribe these drugs for critical sleep problems. You can find these drugs are also being used whenever you see someone struggling with anxiety or alcohol withdrawal symptoms.

  • Best Sleeping OTC Pills Australia

In Australia, the laws of TGA are very strict, especially about Schedule compounds including sleeping pills. Doxylamine is the most prescribed and strongest OTC sleeping aid in there which again is an antihistamine. It is only prescribed to sleep-deficient individuals for short-term use and whoever prescribes it will assess the patient’s history first.

Best OTC Sleeping Pills – 2026 Updates

Let’s begin our quest for the safest sleeping pills by presenting the best one in the business.

For anyone who is battling against sleeplessness and occasional insomnia, NooCube Sleep Upgrade is effective one they can get.

When we discussed the best over-the-counter sleeping aid in the world that involves Melatonin and Glycine, nearly all of these compounds can be found in the NooCube Sleep Upgrade formula which is combined under the supervision of experts.

NooCube Sleep Upgrade is a dietary supplement that contains numerous sleep and cognition-friendly ingredients such as BacopaMonnieri, GABA, Alpha GPC, Oat Straw, Cat’s claw extract, L-Theanine, etc. The best part about NooCube Sleep Upgrade is no caffeine is available to stimulate mental jitteriness.

It works faster, it is safer than most compounds found in sleeping pills and the dosage of 4 pills per day will ignite your sleep cycle and let you sleep like a baby after a long time.

Pros

  • Caffeine-free and over the counter sleeping aid with no synthetic melatonin
  • NooCube Sleep Upgrade boosts the synthesis of natural hormones that are required for you to sleep with peace
  • As a herbal supplement, the NooCube Sleep formula has no side effects that are commonly observed with prescription sleeping pills
  • NooCube Sleep Upgrade reduces anxiety and stress levels which affect symptoms of insomnia positively. Users of NooCube reviewed as they experienced a lack of anxiety and mental stress after taking the supplement on a regular basis
  • It aids concentration level and works for better focus, affecting overall lifestyle which is the best choice for insomnia patients
  • Works for adults and individuals who are 55 years or older

Cons

  • NooCube Sleep Upgrade is expensive to some because it contains a whole supply for a month
  • As a natural sleeping aid, the NooCube Sleep Upgrade supplement is hard to find in many countries
  • It can be ordered from the official website of Wolfson Berg Limited

NooCube Over the Counter Sleeping Aid Pricing

The official website of NooCube Sleep Upgrade proposed these packages which can save you 70% of your cash.

  • One-month supply package of NooCube Sleep Upgrade will cost users $64.99
  • Two-month supply package is available for $129.99
  • Five-month supply of NooCube Sleep Upgrade will cost around $194.99

Just when you’ve found out NooCube Sleep Upgrade is a natural sleeping aid and has no side effects, what is even more surprising is the money-back guarantee it provides. NooCube offers a full 60-day money-back guarantee. If the customer is not happy with his/her purchase for any reason, they can simply return it within 60 days, and the manufacturers will refund your purchase price in full.

Conclusion – Over the Counter Sleeping Pills with No Risks!

Sleep cycle interruption could unleash a variety of mental sicknesses and it impacts the overall general creativity of a person. If you are an adult and dealing with insomnia, it is better to find a way rather than making it linger even more so it could turn into a serious thing.

Insomnia is treatable and you can’t believe even a small number of ingredients can be tremendously helpful – the only thing is to consider using it on regular basis. Medicines that you can find at the drugstore or nearby markets will have a heap of compounds that are not natural and may lead to a list of side effects.

NooCube Sleep Upgrade is a effective OTC sleeping aid that can help you attain those good night sleeps faster. 

It has no caffeine so taking it at night won’t limit your creativity or passion for work. Ensuring you will get maximum bedtime and limit screen exposure before going to the bed is the key to attaining faster results from NooCube Sleep Upgrade.

CONTACT:

Company: NooCube

Email: support@noocube.com

Order Phone Support: UK: +44 191 743 4476 / US: +1 (970) 671-7706 (Monday-Friday, 9:00am-5:00pm)

Advertise with us: Info@allprsolution.com

Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs

Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs




Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs

BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#ADCOrum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief Scientific Officer (CSO). Dr. May brings more than 20 years of oncology and immunology research experience with a track record of advancing antibody drug conjugates (ADCs), T-cell engagers, and other next-generation therapeutic platforms from concept to clinical evaluation.


“Chad has repeatedly demonstrated an ability to take bold scientific concepts and advance them into clinical candidates across multiple therapeutic modalities,” said Sung Joo (SJ) Lee, Ph.D., Founder and CEO of Orum. “His leadership experience in ADCs, T-cell engagers, and structure-driven platform design aligns with Orum’s commitment to precision engineering the next generation of degrader-antibody conjugates. Chad’s expertise strengthens our position as a leader in DAC innovation and supports our progress toward meaningful clinical milestones.”

As CSO, Dr. May will provide scientific vision and R&D leadership, guiding the strategic direction, discovery, and advancement of Orum’s pipeline, including the continued evolution of the Company’s proprietary DAC platforms and programs. He will oversee scientific strategy across discovery, translational research, and preclinical development and will play a central role in shaping the next stage of Orum’s technology innovation and pipeline growth.

“The opportunity to join Orum at this stage of growth is incredibly compelling,” said Dr. May. “The Company’s Dual-Precision Targeted Protein Degradation approach provides a powerful foundation for creating new classes of degraders guided by antibody specificity. I am excited to work closely with the talented scientific and leadership teams to advance Orum’s DAC platforms, expand therapeutic applications across cancer and other serious diseases, and drive the next wave of innovation in degrader-antibody conjugates.”

Dr. May joins Orum from Serotiny, where he served as CSO and oversaw the advancement of a novel gene and cell therapy platform through the company’s post-acquisition integration into Johnson & Johnson. Previously, he served as Senior Vice President of Research and Development at Maverick Therapeutics, where he co-founded and built the R&D organization, advanced multiple conditionally active T-cell engager programs into clinical trials, and led the company’s build-to-buy collaboration with Takeda. Earlier in his career, Dr. May held scientific leadership roles at Pfizer, where he led teams developing T-cell engagers and ADCs and advanced several programs into IND-enabling studies and clinical development. His prior work at ImClone Systems involved the design, conjugation, and evaluation of antibody-based therapeutics. Over his career, Dr. May has built and led high-performing scientific teams, contributed to numerous first-in-class program nominations, and authored more than 30 publications and patents.

About Orum’s TPD²® Approach

Orum’s unique Dual-Precision Targeted Protein Degradation (TPD²®) approach builds novel targeted protein degraders combined with the precise cell delivery mechanisms of antibodies to generate innovative, first-in-class, cell-selective TPDs for the treatment of cancer and other serious diseases. Orum has developed new targeted protein degrader payloads to specifically degrade an intracellular target protein within cancer cells via the E3 ubiquitin ligase pathway. Conjugated to antibodies, the payloads are designed to be delivered specifically to target cells and precisely degrade the intracellular target protein of interest.

About Orum Therapeutics

Orum Therapeutics is a public biotech pioneering the development of cell-specific, targeted protein degraders (TPD²®) with the precision of antibody targeting to develop the next generation of degrader antibody conjugates (DACs) for oncology and beyond. The company is advancing its GSPT1-directed TPD² programs and developing novel degrader payloads to expand the potential of targeted protein degradation. Orum’s novel targeted protein degrader payloads are designed to selectively degrade key intracellular proteins, offering a highly targeted approach to treating difficult-to-treat diseases. Orum is located in Lexington, MA, US, and Daejeon, South Korea. For more info, visit www.orumrx.com.

Orum Therapeutics Forward-Looking Statements

This press release contains forward-looking statements that are based on the current expectations and beliefs of Orum Therapeutics, Inc. (“Orum”). Statements in this release regarding matters that are not historical facts, including, but not limited to, statements relating to the development of new classes of degraders; the development of a next generation of degrader-antibody conjugates; the advancement of Orum’s pipeline, including DAC platforms and programs; the expansion of therapeutic applications; the advancement of programs to the clinical stage; and the achievement of clinical milestones are forward-looking statements. These forward-looking statements are based on management’s expectations and assumptions as of the date of this release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, the uncertainty of success in research and development activities; competition from alternative therapies; and risks related to the recruitment and retention of key employees, fluctuating markets and economic conditions, and future fundraising. The forward-looking statements in this presentation speak only as of the date of this release, and Orum undertakes no obligation to update or revise any of the statements. Orum cautions investors not to place considerable reliance on the forward-looking statements contained in this release.

Contacts

Corporate: IR/PR, Orum Therapeutics, media@orumrx.com
Media: Jessica Yingling, Ph.D., President, Little Dog Communications Inc., jessica@litldog.com

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia




Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at 8:30 a.m. ET to provide an update on PALSONIFY™ (paltusotine) commercialization and disclose topline results from the fourth cohort of the Phase 2 trial of atumelnant in congenital adrenal hyperplasia.

Conference Call and Webcast Details
Management will hold a live conference call and webcast on Monday, January 5, 2026 at 8:30 a.m. ET. A live question-and-answer session will follow the prepared remarks. To access the live audio-only webcast, click here. The archived webcast will also be accessible on the Events & Presentations page in the Investors section of the Crinetics’ website at www.crinetics.com/events. To participate, please dial 1-833-470-1428 (domestic) or 1-646-844-6383 (international) and refer to Access Code 640078.

ABOUT CRINETICS PHARMACEUTICALS
Crinetics Pharmaceuticals is a global pharmaceutical company committed to transforming the treatment of endocrine diseases and endocrine-related tumors through science rooted in patient needs. Crinetics is focused on discovering, developing, and commercializing novel therapies, with a core expertise in targeting G-protein coupled receptors (GPCRs) with small molecules that have specifically tailored pharmacology and properties.

Crinetics’ lead product, PALSONIFY™ (paltusotine), is the first once-daily, oral treatment approved by the U.S. FDA for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option. Paltusotine is also in clinical development for carcinoid syndrome associated with neuroendocrine tumors. Crinetics’ deep pipeline of 10+ disclosed programs includes late-stage investigational candidate atumelnant, which is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome, and CRN09682, a nonpeptide drug conjugate candidate that is being developed to treat SST2 expressing neuroendocrine tumors and other SST2 expressing solid tumors. Additional discovery programs address a variety of endocrine conditions such as neuroendocrine tumors, Graves’ disease (including Graves’ hyperthyroidism and Graves’ orbitopathy, or thyroid eye disease), polycystic kidney disease, hyperparathyroidism, diabetes, obesity, and GPCR-targeted oncology indications.

Investors:
Gayathri Diwakar
Head of Investor Relations
gdiwakar@crinetics.com
(858) 345-6340

Media:
Natalie Badillo
Head of Corporate Communications
nbadillo@crinetics.com
(858) 345-6075

SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement

SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement




SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Court’s interlocutory order governing the Company’s board composition and corporate actions pending trial, and announced the engagement of Zhonghua Certified Public Accountants LLP (“Zhonghua”), an affiliate of the global accounting network UHY International, as the Company’s independent auditor and registered public accounting firm.

Update on Antigua High Court Order

Further to the order issued by the Antigua High Court (the “Court”) previously disclosed by the Company in a press release dated December 17, 2025, the Court has updated its order to provide that directors Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Dr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y. Yan and Mr. Weidong Yin (collectively, the “Board”), will comprise the Board of the Company until the trial listed in late April/early May 2026. Ms. Rui-Ping Xiao has resigned from the Board due to personal reasons. Seven of nine of the Board members are independent and 100% of the members of the Company’s Audit, Compensation and Nominating & Corporate Governance Committees are independent.

Update on Auditor Engagement

The Company further announced that the Audit Committee of the Board approved the engagement of Zhonghua as the Company’s independent auditor effective December 31, 2025. The change was not made due to any disagreements with UHY LLP. Zhonghua is a public accounting firm registered in the People’s Republic of China and is also registered with the Public Company Accounting Oversight Board (PCAOB) in the United States. Zhonghua is a member of UHY International, one of the world’s leading accounting networks; its engagement supersedes that of UHY LLP, which is part of the same global network.

This development follows the Company’s previously announced update regarding auditor engagement and will support SINOVAC’s continued focus on its financial reporting and audit workstreams. The Company remains committed to completing the requisite audit procedures and regulatory filings as expeditiously as practicable and seeks to maintain compliance with applicable U.S. SEC and Nasdaq requirements.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s or Board’s control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.

The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive®, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.

SINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world’s first inactivated SARS vaccine (Phase I completed), China’s first H5N1 influenza vaccine (Panflu®), the world’s first H1N1 influenza vaccine (Panflu.1®), and CoronaVac®, the most widely used inactivated COVID-19 vaccine globally.

Beyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.

With a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.

For more information, please see the Company’s website at www.sinovac.com.

Contacts

Investor and Media Contact

Sinovac Biotech Ltd.

Email: ir@sinovac.com

Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report

Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report




Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq Listing Qualifications (“Nasdaq”), stating that the Company was not in compliance with Nasdaq’s Listing Rule 5250(c)(2) since the Company did not timely file a Form 6-K containing an interim balance sheet and income statement as of the end of its second quarter of year 2025.

As previously disclosed, the Company received a delisting determination letter (the “Staff Determination”) from Nasdaq in November 2025. The Company requested a hearing before the Nasdaq Hearings Panel to appeal the Staff Determination on November 19, 2025. Nasdaq has informed the Company that the Nasdaq Hearings Panel will also consider the matter addressed in the Notification Letter at a hearing scheduled for January 8, 2026 at which the Company has been invited to present its views regarding this matter.

The Company is evaluating the Notification Letter and intends to present its plan and views to the Nasdaq Hearings Panel at the scheduled hearing with the objective of maintaining its Nasdaq listing.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s or Board’s control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.

The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive®, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.

SINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world’s first inactivated SARS vaccine (Phase I completed), China’s first H5N1 influenza vaccine (Panflu®), the world’s first H1N1 influenza vaccine (Panflu.1®), and CoronaVac®, the most widely used inactivated COVID-19 vaccine globally.

Beyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.

With a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.

For more information, please see the Company’s website at www.sinovac.com.

Contacts

Investor and Media Contact

Sinovac Biotech Ltd.

Email: ir@sinovac.com

CJC 1295 Ipamorelin Unveiled 2026: Examining the Science Behind CJC-1295 Peptides and Growth Hormone Stack for Muscle Growth By CrazyBulk

CJC 1295 Ipamorelin Unveiled 2026: Examining the Science Behind CJC-1295 Peptides and Growth Hormone Stack for Muscle Growth By CrazyBulk




CJC 1295 Ipamorelin Unveiled 2026: Examining the Science Behind CJC-1295 Peptides and Growth Hormone Stack for Muscle Growth By CrazyBulk

Discover how CJC-1295 peptide stack research has influenced CrazyBulk’s Growth Hormone Stack, designed to support recovery speed, lean muscle, and training output.

Intro

New York City, NY, Jan. 04, 2026 (GLOBE NEWSWIRE) —  Amid continued global interest in performance science, recovery research, and hormone-related wellness innovation, growth hormone–focused formulations are receiving renewed attention across medical, fitness, and supplement research communities. Recent industry briefings and research summaries have highlighted increasing discussion around growth hormone–releasing peptides such as CJC-1295 and Ipamorelin, alongside a parallel rise in structured supplement stacks designed to support similar biological pathways through non-peptide formulations. This convergence of peptide science and advanced nutritional engineering has prompted renewed examination of how growth hormone signaling, IGF-1 activity, and recovery mechanisms are being addressed across different regulatory frameworks.

As part of this broader trend, growth hormone stacks developed using evidence-informed ingredient strategies are now being positioned as accessible, research-inspired alternatives that reflect insights drawn from peptide science without crossing into prescription-only territory. CrazyBulk’s Growth Hormone Stack has emerged within this context as a structured formulation approach that integrates multiple products designed to support growth hormone pathways, muscle protein synthesis, recovery signaling, metabolic efficiency, and training performance.

Visit the Official Website For More Details

What Is CJC-1295 Ipamorelin?

CJC-1295 Ipamorelin refers to a peptide pairing widely discussed in clinical and research settings for its role in stimulating endogenous growth hormone release. Rather than supplying synthetic growth hormone directly, these peptides are studied for their ability to interact with receptors involved in natural growth hormone secretion patterns. CJC 1295 stack is a growth hormone–releasing hormone (GHRH) analog, while Ipamorelin functions as a growth hormone secretagogue, collectively supporting pulsatile hormone release rather than continuous elevation.

In research literature, this pairing is often examined for its theoretical ability to elevate growth hormone and downstream insulin-like growth factor-1 (IGF-1) levels while maintaining physiological rhythms. These mechanisms have drawn attention within longevity research, recovery science, and metabolic studies, although peptide therapies remain subject to medical oversight and regulatory limitations.

The relevance of CJC-1295 Ipamorelin to the supplement industry lies not in direct replication, but in conceptual influence. Insights from peptide research have informed how formulators approach ingredient selection, timing strategies, and synergistic combinations aimed at supporting similar biological pathways through nutritional means. Growth hormone stacks such as those developed by CrazyBulk reflect this translation of peptide science into structured supplement systems designed for broader accessibility.

Understanding CJC-1295 Ipamorelin provides context for why growth hormone signaling has become a focal point in modern performance supplementation. Rather than replacing natural processes, the emphasis has shifted toward supporting the body’s own anabolic and recovery mechanisms through evidence-aligned formulation strategies.

Inspired by growth hormone and peptide research – Visit the Official CrazyBulk Website

Understanding Ipamorelin and Growth Hormone Signaling

Ipamorelin is primarily studied for its selective interaction with ghrelin receptors involved in growth hormone release. Unlike earlier secretagogues, Ipamorelin has been examined for its relative specificity, meaning it is less associated with stimulation of cortisol or prolactin pathways in research contexts. This selectivity has made it a point of interest in discussions around controlled growth hormone modulation.

Growth hormone signaling itself plays a multifaceted role in the body, influencing protein synthesis, tissue repair, metabolic regulation, and cellular regeneration. Rather than acting continuously, growth hormone is released in pulses, particularly during deep sleep and post-exercise recovery periods. This pulsatile nature is considered central to its physiological effectiveness.

Supplement developers have closely studied these signaling patterns when designing growth hormone–supportive formulations. Rather than aiming for artificial elevation, modern stacks emphasize nutrient timing, amino acid availability, and hormonal support pathways that align with natural secretion cycles. CrazyBulk’s Growth Hormone Stack reflects this approach by incorporating compounds associated with nitric oxide activity, protein synthesis support, testosterone optimization, and metabolic activation.

By understanding how Ipamorelin functions within growth hormone signaling research, it becomes clearer why supplement stacks focus on indirect pathway support rather than hormone replacement. The objective is alignment with biological rhythms, an approach increasingly reflected in next-generation performance formulations.

Train harder, recover faster, and stay ready for the next challenge

The Science Behind Growth Hormone Pulses and IGF-1 Activity

Growth hormone exerts many of its long-term physiological effects through stimulation of insulin-like growth factor-1 (IGF-1), primarily produced in the liver. IGF-1 plays a key role in muscle cell growth, tissue repair, and anabolic signaling, making it central to performance and recovery research. Importantly, IGF-1 activity is influenced not only by total growth hormone levels but by the timing and amplitude of growth hormone pulses.

Research suggests that pulsatile growth hormone release leads to more efficient receptor signaling and downstream anabolic effects compared to sustained elevation. This insight has influenced both peptide research and supplement formulation strategies. Rather than focusing on constant stimulation, modern approaches emphasize conditions that support natural pulses—such as sleep quality, nutrient availability, and post-training recovery environments.

CrazyBulk’s Growth Hormone Stack is structured around this principle. Each component is designed to support a specific aspect of the anabolic environment, from nitric oxide–mediated nutrient delivery to testosterone support and metabolic efficiency. By addressing multiple inputs that influence growth hormone and IGF-1 activity, the stack reflects a systems-based approach inspired by endocrine research.

This emphasis on biological timing and signaling efficiency represents a shift away from simplistic single-ingredient products toward integrated performance systems grounded in hormone science.

CJC-1295-inspired muscle growth with faster recovery cycles – Visit the Official CrazyBulk Website

How CJC-1295 Peptides Work in the Body

CJC-1295 peptides are studied for their ability to bind to GHRH receptors in the pituitary gland, thereby promoting endogenous growth hormone release. Variants with extended half-life have been explored for their capacity to sustain elevated growth hormone signaling over longer periods while preserving pulsatility. This mechanism has been central to discussions around growth hormone optimization in clinical research.

Rather than acting directly on muscle tissue, CJC 1295 stack influences upstream hormonal signaling that affects protein synthesis, fat metabolism, and recovery processes. These systemic effects explain why growth hormone research extends beyond bodybuilding into aging, metabolic health, and regenerative studies.

Supplement developers draw from these insights by focusing on ingredients that influence similar upstream mechanisms—supporting hormonal balance, nutrient signaling, and recovery capacity. CrazyBulk’s Growth Hormone Stack applies this logic by combining compounds that address anabolic signaling from multiple angles rather than relying on a single pathway.

This translation of peptide research into supplement design underscores the evolving sophistication of performance nutrition, where hormonal science informs formulation architecture without replicating pharmaceutical interventions.

Optimize recovery and muscle growth the CJC-1295 way – Visit the Official CrazyBulk Website

Why CJC-1295 and Ipamorelin Are Commonly Paired

In research contexts, CJC-1295 and Ipamorelin are often discussed together due to their complementary mechanisms. While CJC-1295 stimulates growth hormone release via GHRH pathways, Ipamorelin activates ghrelin receptors, resulting in synergistic stimulation of growth hormone pulses. This pairing has become a reference point in discussions about optimized hormone signaling.

The concept of synergy has been widely adopted in supplement formulation. Rather than isolating single ingredients, growth hormone stacks integrate multiple compounds that work through different but complementary pathways. CrazyBulk’s Growth Hormone Stack mirrors this principle by combining products that support nitric oxide production, anabolic signaling, testosterone levels, and metabolic activation.

This systems-based approach reflects lessons drawn from peptide pairing research: effective performance support often requires coordinated input across multiple physiological systems.

Research Insights on Body Composition, Recovery, and Performance

Growth hormone and IGF-1 signaling are consistently linked in research to lean mass maintenance, tissue repair, and recovery efficiency. Studies examining growth hormone modulation frequently explore outcomes related to muscle protein synthesis, fat metabolism, and exercise recovery timelines.

While peptide therapies operate under medical supervision, supplement stacks apply these insights through nutritional strategies. CrazyBulk’s Growth Hormone Stack is structured to support training adaptation by enhancing nutrient delivery, supporting anabolic hormones, and promoting efficient recovery environments.

By integrating multiple performance-focused compounds, the stack reflects a holistic interpretation of growth hormone research rather than a narrow focus on muscle size alone.

CJC-1295 principles, translated into a complete growth system – Visit the Official CrazyBulk Website

Growth Hormone Stacks: How Peptide Research Has Influenced Supplement Formulas

Advances in peptide research have significantly shaped how modern supplement formulas approach growth hormone support. Rather than attempting to replicate pharmaceutical or peptide-based interventions, contemporary growth hormone stacks are designed to reflect the underlying biological principles observed in research settings—namely hormonal signaling efficiency, nutrient timing, and synergistic pathway activation. This evolution has led to multi-component systems that address growth hormone–related processes indirectly through nutrition and performance science.

CrazyBulk’s Growth Hormone Stack exemplifies this research-informed approach. Drawing conceptual inspiration from peptide studies involving compounds such as CJC-1295 Ipamorelin, the stack focuses on creating an internal environment conducive to anabolic signaling, recovery processes, and metabolic efficiency. Instead of single-ingredient supplementation, the formulation strategy integrates multiple products, each aligned with a distinct physiological role.

Peptide research emphasizes pulsatile hormone release, downstream IGF-1 activity, and coordinated endocrine signaling. These insights have influenced how CrazyBulk structures its stack—combining nitric oxide support, amino acid delivery, testosterone optimization, connective tissue support, and metabolic activation into a unified system. The result is a supplement architecture designed to function cohesively rather than in isolation.

This approach reflects a broader shift in the supplement industry toward systems-based formulation, where performance outcomes are supported through multiple complementary mechanisms. By aligning supplement design with established research concepts from peptide science, CrazyBulk’s Growth Hormone Stack positions itself within a new generation of performance nutrition that prioritizes biological alignment, formulation synergy, and structured functionality.

Visit the Official Website For More Details on CJC 1295 Stack

Benefits of CJC-1295 Peptide Supplements for Men

In research and clinical discussions, CJC-1295 peptide supplementation is often examined in the context of male physiology due to its association with growth hormone signaling, metabolic regulation, and recovery processes. Growth hormone plays a central role in maintaining lean tissue, supporting protein synthesis, and facilitating tissue repair—functions that are particularly relevant to male performance, aging, and training adaptation.

Studies exploring growth hormone–releasing peptides frequently reference outcomes related to body composition balance, connective tissue health, and exercise recovery efficiency. While peptide therapies are typically administered under medical supervision, the underlying biological benefits discussed in research literature have informed how supplement developers approach male-focused performance formulations.

For men, growth hormone–related pathways are closely linked to muscle maintenance, fat metabolism, and overall physical resilience. Research insights suggest that supporting these pathways may contribute to improved training recovery cycles, enhanced nutrient utilization, and sustained anabolic signaling. These concepts have become foundational in the development of growth hormone–inspired supplement stacks.

CrazyBulk’s formulation philosophy reflects these principles by targeting multiple inputs that influence male performance systems. Rather than addressing a single outcome, the focus is on supporting the broader hormonal and metabolic environment associated with growth hormone activity. This research-aligned approach underscores why growth hormone science continues to influence product development aimed at male wellness and performance contexts.

Build muscle using the same science behind CJC-1295 – Visit the Official CrazyBulk Website

How CrazyBulk Growth Hormone Stacks Benefit Muscle Growth & Strength

CrazyBulk’s Growth Hormone Stack is structured as a multi-product system designed to support muscle development and strength output through complementary mechanisms. Each component plays a defined role within the overall formulation strategy, contributing to an integrated performance framework rather than isolated effects.

HGH-X2 is formulated to support nitric oxide pathways and amino acid signaling, which are associated with nutrient delivery and anabolic processes. Deca-Max focuses on connective tissue support and recovery pathways, aligning with research emphasizing joint integrity and tissue resilience in strength training contexts. D-Bal is designed around protein synthesis support, addressing one of the core drivers of muscle development. Testo-Max targets testosterone-related pathways, which play a synergistic role alongside growth hormone in muscle strength and performance. Clenbutrol contributes to metabolic activation and energy utilization, supporting lean mass maintenance during intense training phases.

Together, these products form a coordinated system that supports muscle growth and strength through multiple biological inputs. Rather than relying on a single mechanism, the stack emphasizes formulation synergy, reflecting principles derived from endocrine and performance research. This integrated design allows the Growth Hormone Stack to address training adaptation, recovery capacity, and muscular output in a structured and research-informed manner.

Push past plateaus with CJC-1295-based formulation logic

CrazyBulk Growth Hormone Stack: Linking CJC-1295 Science to Muscle Growth, Recovery, and Fat Reduction

Ongoing research into growth hormone–releasing peptides such as CJC-1295 has placed renewed emphasis on the role of recovery efficiency, metabolic balance, and anabolic signaling in long-term muscle development. One of the most widely discussed benefits associated with CJC-1295 research is its relationship to improved recovery cycles, reduced training downtime, and support for lean muscle preservation during intense physical stress. These same principles now inform the design of advanced growth hormone–inspired supplement systems.
CrazyBulk’s Growth Hormone Stack has been structured around these core concepts. Rather than acting as a direct hormone intervention, the stack focuses on supporting the physiological conditions commonly associated with growth hormone activity—enhanced nutrient delivery, improved protein synthesis efficiency, optimized hormonal balance, and metabolic activation. Together, these factors contribute to faster recovery between sessions, allowing the body to remain primed for repeated training challenges.
Recovery speed plays a critical role in muscle growth. When downtime is reduced, training frequency and output can be maintained more consistently, supporting progressive overload and strength adaptation. The CrazyBulk Growth Hormone Stack addresses this by combining compounds that support connective tissue integrity, cellular repair processes, and anabolic signaling pathways. This aligns closely with the recovery-focused benefits frequently discussed in CJC-1295 peptide research.
In parallel, growth hormone–related pathways are also linked to fat metabolism and body composition regulation. By supporting metabolic efficiency and energy utilization, the stack contributes to an environment where lean muscle development is prioritized while excess fat storage is minimized. This dual focus on muscle growth and fat reduction reflects the holistic outcomes often associated with optimized growth hormone signaling.
As training demands increase, the body’s ability to recover, rebuild, and adapt becomes the limiting factor for muscle gains. CrazyBulk’s Growth Hormone Stack positions itself as a research-inspired performance system designed to support these processes—helping the body stay prepared for the next physical challenge while maintaining momentum toward substantial muscle development.

Where to Buy CrazyBulk’s Growth Hormone Stacks Safely

CrazyBulk’s Growth Hormone Stack is made available through official website designed to maintain product integrity, formulation accuracy, and quality assurance. Purchasing directly through authorized sources ensures that consumers receive products that align with published specifications, ingredient standards, and manufacturing controls.

Official availability also provides access to up-to-date formulation details, usage information, and batch-controlled production processes. This centralized distribution approach reflects industry best practices for supplement safety, transparency, and consistency. By maintaining controlled supply channels, CrazyBulk supports accountability across sourcing, production, and delivery stages.

Accessing the Growth Hormone Stack through verified platforms helps ensure alignment with regulatory requirements and brand-established quality benchmarks. This structured distribution model reinforces the company’s focus on reliability and product standardization within the performance supplement market.

Who May Consider CJC-1295 Stack in a Medical or Wellness Setting

CJC-1295 Ipamorelin is generally discussed within medical or wellness frameworks that involve professional oversight. Research and clinical use cases often focus on growth hormone signaling support in contexts such as age-related hormonal changes, recovery limitations, or metabolic considerations. Due to its classification and mechanism, peptide therapy is typically explored under the guidance of licensed healthcare practitioners.

Individuals considering peptide-based approaches are advised to undergo proper evaluation to determine suitability, dosing frameworks, and monitoring protocols. This ensures that growth hormone modulation is addressed within appropriate clinical parameters. The distinction between peptide therapies and supplement-based alternatives remains an important consideration in wellness planning.

While supplement stacks draw conceptual inspiration from peptide research, peptide therapies themselves remain part of regulated medical discussions. Understanding this separation helps clarify the role of CJC-1295 Ipamorelin within professional healthcare settings versus nutritional performance strategies.

Final Thoughts: CJC-1295 Peptides Have a New Name—CrazyBulk

As growth hormone research continues to influence wellness and performance innovation, its principles are increasingly reflected in advanced supplement systems. CrazyBulk’s Growth Hormone Stack represents a research-inspired interpretation of growth hormone science, translating complex endocrine concepts into a structured nutritional framework.

Rather than replicating peptide therapies, the stack applies lessons from hormonal research—synergy, timing, and pathway support—through legally accessible formulations. This approach highlights how peptide science has shaped modern supplement architecture, positioning CrazyBulk as a brand aligned with next-generation performance formulation strategies.

By integrating multiple performance-supporting components into a cohesive system, CrazyBulk’s Growth Hormone Stack reflects the ongoing convergence of research insight and nutritional innovation within the evolving performance science landscape.

For more information on CJC 1295 Stack, educational content, and direct purchasing, visit the official CrazyBulk  website
Project name: Crazybulk
244 Madison Avenue,
New York City, NY 10016-2817
Postal code: NY 10016-2817
Media Contact:
email: support@crazybulk.com
+1 888-708-6394
Company website: https://www.crazybulk.com/

Disclaimers

Publisher Responsibility Disclaimer: The publisher of this article has made every effort to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with the official source before making a purchase decision.

FDA Disclaimer: CrazyBulk is a dietary supplement and has not been evaluated by the U.S. Food and Drug Administration (FDA). It is not intended to diagnose, treat, cure, or prevent any disease.

Health Disclaimer: The information provided in this article is for educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before beginning any new supplement, especially if you have a medical condition or are taking prescription medication.

Results Disclaimer: Individual results may vary. Some users report noticeable benefits, while others experience little to no change. Factors such as diet, lifestyle, and overall health can influence outcomes.

Pricing Disclaimer: Product prices, bundles, and promotions for CrazyBulk are subject to change at any time without notice. Always check the official website for the most current details.

Attachment

CONTACT: Project name: Crazybulk
244 Madison Avenue,
New York City, NY 10016-2817
Postal code: NY 10016-2817
Media Contact:
email: support@crazybulk.com
+1 888-708-6394
Company website: https://www.crazybulk.com/

Nia Therapeutics Publishes Peer-Reviewed Validation of a 60-Channel Brain Implant for Closed-Loop Neurostimulation

Nia Therapeutics Publishes Peer-Reviewed Validation of a 60-Channel Brain Implant for Closed-Loop Neurostimulation




Nia Therapeutics Publishes Peer-Reviewed Validation of a 60-Channel Brain Implant for Closed-Loop Neurostimulation

Wireless Smart Neurostimulation System records from 10× more brain sites than current adaptive implants; a large-animal study demonstrates chronic sensing, neural-state decoding, and programmable stimulation




ALLSTON, Mass.–(BUSINESS WIRE)–Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation System (SNS), a wireless, implantable brain-computer interface designed for closed-loop treatment of memory disorders.

The SNS records neural activity from 60 channels across four brain regions—an order-of-magnitude increase over commercially available devices. The NeuroPace RNS system, FDA-cleared for epilepsy, records from up to six channels; Medtronic’s Percept adaptive DBS system records from up to four.

This expanded sensing capacity reflects the distributed nature of memory, which arises from coordinated dynamics across widespread neural networks rather than from a single focal site.

“Most brain implants were developed for conditions in which a localized abnormal signal drives symptoms,” said Michael J. Kahana, PhD, co-founder and CEO of Nia Therapeutics and a professor at the University of Pennsylvania. “Decades of research show that memory depends on coordinated activity across distributed networks. The SNS was engineered to detect these patterns and respond with personalized stimulation.”

Preclinical Validation in Freely Moving Large Animals

In a chronic study of three sheep, the SNS demonstrated stable performance across core functions:

  • Neural-state decoding. Machine-learning classifiers distinguished movement from stillness with high accuracy (AUC 0.92–0.98), with performance stable throughout implantation.
  • Programmable neuromodulation. Systematic variation of stimulation parameters produced dose-dependent changes in alpha-band (8–12 Hz) and gamma-band (78–82 Hz) neural activity, confirming that stimulation reliably modulates physiological signals.
  • Biocompatibility. Histological analyses showed no adverse tissue response, with findings comparable to a commercially available control lead.

These results demonstrate that the SNS can chronically record distributed neural activity, decode behaviorally relevant brain states, and deliver stimulation with predictable effects—key prerequisites for future closed-loop neurostimulation therapies.

Building on a Decade of Human Memory Research

The SNS builds on federally funded research supported by DARPA and NIH. In prior human studies using externalized research systems, Kahana and colleagues recorded intracranial brain activity from hundreds of epilepsy patients performing memory tasks and showed that machine-learning models could predict, moment by moment, whether newly learned information would be remembered.

In sham-controlled clinical experiments, brief bursts of electrical stimulation delivered during classifier-identified poor-encoding states improved delayed recall by approximately 20%; stimulation delivered at random times produced no benefit. Those studies established the therapeutic principle underlying Nia’s approach but relied on devices unsuitable for chronic use.

This publication shows that the core capabilities required for memory-guided stimulation—high-density sensing, real-time decoding, and programmable neuromodulation—can be delivered in a fully implantable, wireless system,” said Daniel S. Rizzuto, PhD, co-founder and President of Nia Therapeutics.

Addressing an Unmet Clinical Need

Memory impairment is among the most common and disabling consequences of traumatic brain injury and age-related cognitive decline. Although recent disease-modifying drugs for early Alzheimer’s can slow progression, they do not restore lost function. Nia’s approach aims to complement such treatments by directly improving memory through targeted neuromodulation.

Nia Therapeutics is preparing for first-in-human studies, with regulatory submissions planned for 2026. The initial study will focus on patients with memory loss resulting from moderate-to-severe traumatic brain injury.

About Nia Therapeutics

Nia Therapeutics develops implantable brain-computer interfaces for memory disorders. Founded in 2018, the company’s SNS device supports closed-loop neuromodulation by detecting brain states linked to impaired memory encoding and delivering targeted stimulation. Visit www.niatx.com.

Publication Reference

Rizzuto DS, Herrema HG, Hu Z, Utin D, Kahn J, Ho C, Smiles A, Gross RE, Lega BC, Das SR, Kahana MJ. A wireless, 60-channel, AI-enabled neurostimulation platform. Brain Stimulation (2025). DOI: https://doi.org/10.1016/j.brs.2025.103013

Contacts

Media Contact
Michael Kahana, PhD, CEO, Nia Therapeutics, mike@niatx.com